Sanofi Cements RSV Dominance As Merck & Co. Rival Awaits FDA D-Day

The French company will start shipping its blockbuster shortly to meet expected strong demand in the 2025–26 RSV season.

RSV illus
• Source: Shutterstock

More from Manufacturing

More from Therapy Areas